Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: The POPI (prevention of pelvic infection) trial

BMJ (Online)

Volumn 340, Issue 7752, 2010, Pages 903-

  Oakeshott, Pippa ^a   Kerry, Sally ^a   Aghaizu, Adamma ^a   Atherton, Helen ^b   Hay, Sima ^c   Taylor Robinson, David ^b   Simms, Ian ^d   Hay, Phillip ^e  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING; SEXUAL BEHAVIOR; SYMPTOM; VAGINA SMEAR;

ADOLESCENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INCIDENCE; LONDON; MASS SCREENING; MIDDLE AGED; PELVIC INFLAMMATORY DISEASE; SEXUAL BEHAVIOR; SEXUAL PARTNERS; YOUNG ADULT;

EID: 77951602390     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1642     Document Type: Article

References (26)

1. Centers for Disease Control. Sexually transmitted diseases treatment guidelines. MMWR 2006;55:56-57
2. European Centre for Disease Prevention and Control. Chlamydia control in Europe. ECDC, 2009.
3. National Institute for Health and Clinical Excellence. Revised rapid review of evidence for the effectiveness of screening for genital chlamydia infection in sexually active young women and men. NICE, 2006.
4. Scholes D, Stergachis A, Heidrich F, Andrilla H, Holmes K, Stamm W. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection.N Engl J Med 1996;334:1362-1366
5. Abter E, Mahmud M. Screening for chlamydia to prevent pelvic inflammatory disease.N Engl J Med 1996;335:1531.
6. Sellors J, Paavonen J. Screening to prevent pelvic inflammatory disease.N Engl J Med 1996;335:1531-1532
7. Pittrof R. Screening for chlamydia to prevent pelvic inflammatory disease.N Engl J Med 1996;335:1532.
8. Low N, Bender N, Nartey L, Shang A, Stephenson J. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol 2009;38:435-448
9. Ostergaard L, Andersen B, Moller JK. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster randomised 1-year follow-up study. Clin Infect Dis 2000;31:951-957 (Pubitemid 32299353)
10. Low N, Egger M, Sterne JAC, Harbord R, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort study. Sex Transm Infect 2006;82:212-218 (Pubitemid 43901588)
11. Peterman T, Gottlieb S, Berman S. Commentary: Chlamydia trachomatis screening - what are we trying to do? Int J Epidemiol 2009;38:449-451
12. Simms I, Horner PJ. Has the incidence of pelvic inflammatory disease following chlamydia infection been overestimated? Int J STD AIDS 2008;18:285.
13. Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial. Trials 2008;9:73.
14. Ivaz S, Dean S, Hay P, Hay S, Kerry S, Oakeshott P. Lessons learned from recruiting young female students to a randomised controlled trial of chlamydia screening. Fam Pract 2006;23:188-191
15. Atherton H, Banks D, Hay P, Kerry S, Simms I, Oakeshott P. Recruitment of young women to a trial of chlamydia screening - as easy as it sounds? Trials 2007;8:41.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation 36. J Clin Microbiol 1991;29:297-301.
17. Oakeshott P, Hay P, Hay S, Steinke F, Rink E, Kerry S. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study. BMJ 2002;325:1334-1336 (Pubitemid 35471552)
18. Hager D, Eschenbach D. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983;61:113-114
19. Ness RB, Hillier SL, Kip K, Soper D, Stamm CA, McGregor JA, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004;104:761-769 (Pubitemid 40458806)
20. Miettinen OS, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-226
21. Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections 1. Sex Transm Dis 2005;32:725-728 (Pubitemid 41752557)
22. Ness R, Soper D, Holley RL, Peipert J, Randall MD, Sweet R, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomised trial. Am J Obstet Gynecol 2002;186:929-937
23. Simms I, Rogers P, Charlett A. The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS 1999;10:448-451 (Pubitemid 29312829)
24. Adams EJ, Turner K, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Inf 2007;83:267-275
25. Low N, Ward H. Focus on chlamydia. Sex Transm Inf 2007;83:251-252
26. Gaydos CA, Wright C, Wood BJ, Waterfield G, Hobson S, Quinn TC. Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers. Sex Transm Dis 2008;35:233-237